Naviter Wealth, LLC Brooklyn Immuno Therapeutics, Inc. Transaction History

Naviter Wealth, LLC

  • $710 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022
BUY
$0.48 - $2.03 $814 - $3,442
1,696 Added 0.11%
1,572,803 $814,000
Q1 2022

Apr 21, 2022
BUY
$1.76 - $4.84 $27,228 - $74,879
15,471 Added 0.99%
1,571,107 $3.22 Million
Q4 2021

Feb 03, 2022
BUY
$4.17 - $9.79 $6.49 Million - $15.2 Million
1,555,636 New
1,555,636 $6.49 Million

Others Institutions Holding BTX

# of Institutions
1
Shares Held
1.21M
Call Options Held
0
Put Options Held
0
View Full List

About Brooklyn ImmunoTherapeutics, Inc.

BTX Quotes by TradingView
  • Ticker BTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,825,700
  • Description
  • Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...
More about BTX
Track This Portfolio

Track Naviter Wealth, LLC Portfolio

Follow Naviter Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Naviter Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naviter Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email